Vaginal thrush is common, with three in every four women of reproductive age likely to be affected. But fungal infections are ...

Discover the challenges of treating resistant vaginal thrush and the rise of non-albicans Candida species. Learn about new ...

However, systemic combination treatments can result in severe adverse effects, suggesting the need for localised delivery systems, such as drug-loaded electrospun patches, to administer antifungals ...

Vraylar (cariprazine) is a prescription drug that’s used to treat certain mental health conditions, such as schizophrenia. The drug comes as a capsule that you swallow. It’s usually taken once ...

neoformans infection may alter its efficacy, [59] and that fluconazole dosage must be increased in the case of severe cerebral cryptococcosis. [60] This is an important issue because patients in ...

Fluconazole is also available as an oral suspension ... is no better than that of standard dose griseofulvin, it may still be useful in select patients with a contraindication to or intolerance ...

Wegovy (semaglutide) is a brand-name drug prescribed for weight management in adults and some children. Wegovy comes as a solution in single-use injection pens. It’s typically injected once per ...

Tremfya (guselkumab) is a prescription drug that’s used to treat certain inflammatory conditions, such as psoriatic arthritis. Tremfya comes as a liquid solution for injection. If you’d like ...

Extra Strength Tylenol relieves pain and discomfort caused by many conditions, including the common cold and arthritis. However, you must be careful not to exceed the maximum daily dose. An overdose ...

The work resulted in liraglutide, the first long-lasting GLP-1-based drug, approved by the US Food and Drug Administration in 2010 for type 2 diabetes. In the meantime, researchers were already ...

It was released in advance of a United Nations General Assembly meeting later this month on drug-resistant pathogens. “The numbers in the Lancet paper represent a staggering and unacceptable ...

The report, published on 16 September in The Lancet 1, found that between 1990 and 2021, more than one million people died from drug-resistant infections each year, and this could increase to ...